Schedule 13G ownership disclosure

ASPIRE BIOPHARMA HLDGS INC

Common Stock · CUSIP: 738920107

Event date: 2025-04-29

Filing-level shares
3,872,386.00
Percent of class
7.92%
  • Lance Friedman

    Shares: 3,872,386.00 · Class: 7.92%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001641172-25-009072
Form type
SCHEDULE 13G/A
Filer
Aspire Biopharma Holdings, Inc.
CIK
CIK 1847345
Filed
May 07, 2025
Reporting period
Apr 29, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub